MSD Acquires CN201 from Curon Biopharmaceutical, Advancing B-cell Disease Treatments

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced the completion of the acquisition of CN201 from Curon Biopharmaceutical ...

October 02, 2024 | Wednesday | News
Piramal Pharma Commits $80M to Transform Lexington Facility, Elevating Global Sterile Injectables Production

$80M investment plan will add commercial scale sterile injectables capabilities Expansion will significantly increase pr...

October 01, 2024 | Tuesday | News
Abzena's AbZelectPRO™ Platform Reduces Cell Line Development Timelines by 30%, Boosts Protein Production for Biopharma

Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, has announced that its mammalian cell line development platform, ...

September 27, 2024 | Friday | News
Agarose Bead Technologies Completes Major Expansion of Spanish Facility to Meet Global Demand for Pharmaceutical Resins

Agarose Bead Technologies (ABT), a leading manufacturer of high-quality agarose resins, proudly announces the completion of a major expansion at its faci...

September 25, 2024 | Wednesday | News
VERDOT® to Build New 4,200 Square-Meter Headquarters and Manufacturing Facility in Riom, France

4200 square-meter headquarter and manufacturing facility in Riom, France Consolidation of existing facilities with 150% additional manufacturing capacit...

September 23, 2024 | Monday | News
Australian Telix Pharmaceuticals to Acquire U.S. Radiopharmacy Network RLS in $230M Deal

Telix Pharmaceuticals Limited announced an agreement to acquire RLS (USA) Inc. (RLS), America's only Joint Commission-accredited radiopharmacy network sp...

September 23, 2024 | Monday | News
Nicox’s ZERVIATE® Approved for Ocular Itching in China, Set to Launch with Ocumension Therapeutics

Nicox’s partner, Ocumension Therapeutics, has received approval for ZERVIATE® for ocular itching in China ZERVIATE® launch in China wil...

September 18, 2024 | Wednesday | News
Shuttle Pharmaceuticals Expands Phase 2 Glioblastoma Trial with Two Additional Sites

Shuttle Pharmaceuticals Holdings, a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients tr...

September 17, 2024 | Tuesday | News
FDA Approves TREMFYA® as First Dual-Acting Interleukin-23 Inhibitor for Ulcerative Colitis Treatment

The first and only dual-acting interleukin-23 inhibitor approved in active ulcerative colitis, TREMFYA® showed highly statistically signifi...

September 12, 2024 | Thursday | News
Gilead and Genesis Partner to Leverage GEMS AI Platform for Small Molecule Drug Discovery

Gilead and Genesis Will Leverage the GEMS AI Platform to Generate and Jointly Optimize Molecules Against Selected Targets -- -- Gilead Receives Exclus...

September 11, 2024 | Wednesday | News
Symbiosis Pharmaceutical Expands Manufacturing Capacity with New Facility in Stirling

Symbiosis Pharmaceutical Services Ltd (Symbiosis), a rapidly growing sterile biopharmaceutical Contract Manufacturing Organisation (CMO) announces the pu...

September 09, 2024 | Monday | News
Hongene Biotech and ReciBioPharm Forge Strategic Alliance to Enhance Gene Editing Drug Manufacturing

Hongene Biotech Corporation, a global leader in nucleic acid manufacturing, and ReciBioPharm, a leading advanced therapeutics CDMO services provider, hav...

September 09, 2024 | Monday | News
Nxera Pharma to Receive $35 Million Milestone Payment from Neurocrine Following Successful Phase 2 Schizophrenia Trial

Nxera Pharma Co – formerly known as Sosei Group or Sosei Heptares – announces that it will receive a US$35 million payment from Neurocrine Bi...

September 03, 2024 | Tuesday | News
Celltrion USA Expands Patient Access to ZYMFENTRA® Through Agreement with Cigna and Express Scripts

Celltrion USA announced that it has signed an agreement with Cigna Healthcare, the health benefits provider of the Cigna Group and Express Scripts, the p...

August 29, 2024 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close